Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TRECONDI 5 G POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/TRECONDI 5 G POLVO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

TRECONDI 5 G POLVO PARA SOLUCION PARA PERFUSION

Medac Gesellschaft Für Klinische Spezialpräparate Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 2, 2021
Approval ID: bec79a7ac108bb01
Company: Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
Type: Standard

Approval Details

Approval Id: bec79a7ac108bb01
Drug Cima Aemps Name: TRECONDI 5 G POLVO PARA SOLUCION PARA PERFUSION
Register Number: 1181351003
Holder Company Name: Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
Marketing Company Name: Laboratorios Gebro Pharma S.A.
Authorization Date: 2021-02-02
Dosage Form: POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 5 g
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Medac Gesellschaft Für Klinische Spezialpräparate Gmbh

Active Ingredients

TREOSULFANO

5 g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 2, 2021

Approval ID

bec79a7ac108bb01

Type

Standard

Back to CIMA-AEMPS Approvals